Introduction
============

Alcohol use disorders (AUDs) affect approximately 8.5% of the U.S. adult population (Grant et al., [@B12]) and account for \$185 billion in costs related to the psychiatric and medical consequences of heavy drinking (Harwood, [@B13]). Given that the onset of alcoholism occurs largely before age 30, recent studies have focused on genetic and environmental factors that affect young people (Hingson and Zha, [@B19]).

Alcohol use in young adults is especially problematic as early age of first use is associated with a later increase in psychosocial and alcohol-related problems (Tapert et al., [@B40]; Rowe et al., [@B35]). Both genetic and environmental factors contribute to the onset of problem drinking in adolescence and early adulthood. Genetic factors account for an estimated 40--60% of the risk of developing AUDs (Kendler et al., [@B23]; Prescott et al., [@B32]; Schuckit, [@B36]). At the neurobiological level, the serotonin neurotransmitter system appears to be important to alcohol phenotypes via its relation to impulsivity, negative mood, craving, and response to alcohol (Heinz et al., [@B16]; Hinckers et al., [@B18]).

A polymorphism which has been directly associated with alcohol dependence in the 5′ promoter region (*5*-*HTTLPR*) of the serotonin transporter gene (locus ID SLC6A4) is of particular interest to neuropsychiatric genetics, including genetics of alcoholism. This 44-bp deletion/insertion polymorphism results in two common alleles, the 528-bp long allele (L) and the 448-bp short allele (S). The S allele has been shown to decrease transcription and decrease 5-HT reuptake *in vitro* (Heils et al., [@B15]) and *in vivo* (Heinz et al., [@B17]). The L allele has been associated with a predisposition to lowered level of response to alcohol, which is in turn associated with the onset of AUDs (Bleich et al., [@B4]). Additionally, the L allele has been associated with early onset of AUDs, earlier age of first drink (Buchmann et al., [@B6]), higher rates of AUD, a heavier drinking pattern, and higher alcohol craving (Hu et al., [@B20]; Olsson et al., [@B30]; Hinckers et al., [@B18]; Bleich et al., [@B4]).

In contrast to studies reporting an association between the L allele and alcohol problems, there is recent evidence suggesting that the S allele has a small, but direct relationship to the development of AUDs (Feinn et al., [@B11]; McHugh et al., [@B28]). Studies examining gene × environment interactions have produced mixed evidence regarding which allele contributes risk. A meta-analysis of *5-HTTLPR* findings reported that the S allele was more often associated with the development of alcohol problems (Feinn et al., [@B11]). A separate study found that the S allele placed adolescents at risk for alcohol use (Brody et al., [@B5]). Interestingly, although Brody et al. ([@B5]) found that the S allele represented a risk factor for alcohol use in youth, the 17 studies analyzed by Feinn et al. ([@B11]) in their meta-analysis had a mean age range of 39--52 years of age. The relationship between the serotonin transporter polymorphism and AUDs may in fact differ by age, gender, and/or stage of addiction (Philibert et al., [@B31]; Merenakk et al., [@B29]). Contradictory findings regarding *SLC6A4* may also be explained by the heterogeneity of alcohol use phenotypes, including variability in depression and anxiety symptoms (Schuckit and Smith, [@B37]), comorbidity, and age of onset (Johnson, [@B22]; Buchmann et al., [@B6]). The current study examines the interaction between depressive symptoms and *5-HTTLPR* as a predictor of alcohol use and related problems in a sample of heavy-drinking young adults.

Previous work on the interaction effects of the serotonin transporter polymorphism has focused on stress and negative life events as moderators of the development of AUDs. Psychological stress has been found to moderate the effects of the *5-HTTLPR* polymorphism on alcohol use both in non-human primates (Barr et al., [@B3]) and in human samples (Caspi et al., [@B8]). Alcohol use may represent a way to cope with depression and/or anxiety symptoms, suggesting that these symptoms may moderate the relationship between *SLC6A4* and alcohol misuse (Armeli et al., [@B2]). Family history of depression and stressful life events have both been linked to the development of poor coping skills, which have been directly associated with alcohol dependence (Schuckit and Smith, [@B37]). More recently, two copies of the L allele at the *SLC6A4* locus were associated with higher coping motivations to drink (Armeli et al., [@B2]). This relationship was strongest among women, underscoring the role of gender in determining *SLC6A4* contribution to alcohol phenotypes. Genetic studies of family history reveal minimal shared genetic etiology between depression and alcoholism, despite high comorbidity. This is consistent with the hypothesis that symptoms of depression and anxiety may affect AUDs through an indirect path, rather than shared heritability (Swendsen and Merikangas, [@B39]; Kuo et al., [@B24]; Sihvola et al., [@B38]). These findings suggest that the high co-occurrence of depression and AUDs is the result of interactive effects, rather than direct genetic contribution.

Previous work examining the interactive effects of negative life events and stress with the serotonin transporter polymorphism has proved inconclusive. The S allele has been associated with more frequent and heavier drinking in college students who have experienced negative life events (Covault et al., [@B10]). However, the relationship between psychosocial adversity and hazardous drinking in 19-year-old men was such that L allele homozygotes reported more hazardous drinking after adversity than those with either the S allele or psychosocial adversity alone (Laucht et al., [@B26]).

Gender may play a role in explaining the contradictory findings, and has recently been found to affect 5HT mRNA transcription from the *SLC6A4* (Philibert et al., [@B31]). In this study, both the L allele and male sex were associated with increased 5HT mRNA transcription, which in turn was associated with AUDs in the same sample. Gender differences in the incidence of AUDs and depression and also in transcriptional activity at the *SLC6A4* may account for some of the mixed results regarding which allelic variation poses a risk for AUDs. The SS genotype has been associated with heightened risk for depression, a disorder that is more prevalent in women (Caspi, [@B7]; Hasin et al., [@B14]), while AUDs are three times more common in men than women. Additional work is needed to fully elucidate the relationship between the *5-HTTLPR* polymorphism, affective symptoms, and alcohol use; including the relative contribution of age and gender.

To that end, the present study examined the independent and interactive effects of the serotonin transporter polymorphism and depressive symptoms as predictors of alcohol use and alcohol-related problems in a sample of heavy-drinking young adults. It is hypothesized that the LL genotype of the *5-HTTLPR* polymorphism will be associated with higher levels of drinking and alcohol problems, based on previous findings that the L allele results in increased 5HT mRNA transcription and AUDs in a mixed sample of depression and alcohol use disordered patients (Philibert et al., [@B31]). Consistent with recent findings among youth, this relationship is predicted to be stronger at higher levels of depressive symptoms (Laucht et al., [@B26]).

Materials and Methods
=====================

Participants and procedures
---------------------------

Participants (*n* = 72) were heavy drinkers who met the following inclusion criteria: (1) age between 18 and 65; and (2) score of 8 or higher in the alcohol use disorders identification test (AUDIT; Allen et al., [@B1]), indicating a hazardous drinking pattern. Exclusion criteria were: (1) currently receiving treatment for alcohol problems, a history of treatment in the 30-days before enrollment, or currently seeking treatment; (2) a lifetime diagnosis of schizophrenia, bipolar disorder, or psychotic disorder; (3) current and regular (defined as once weekly) use of any psychoactive drug, other than marijuana, as determined by self-report. Sample characteristics are provided in Table [1](#T1){ref-type="table"}.

###### 

**Demographic characteristics by *5-HTTLPR* genotype \[*M* ± (SD)\]**.

                      SS (*n* = 22)    SL (*n* = 22)    LL (*n* = 28)    SS/SL[^1^](#tfn1){ref-type="table-fn"} (*n* = 44) vs. LL (*n* = 28)
  ------------------- ---------------- ---------------- ---------------- ---------------------------------------------------------------------
  Age                 20.36 ± (1.95)   21.45 ± (4.13)   21.48 ± (3.49)   *F*(1, 70) = 1.284, *p* = 0.261
  Gender (male *n*)   13               14               20               χ^2^(2, 72) = 0.865, *p* = 0.649
  Ethnicity (*n*)                                                        χ^2^(2, 68) = 35.75, *p* \< 0.001[\*](#tfn2){ref-type="table-fn"}
  African American    0                1                0                
  Caucasian           11               16               24               
  Asian               9                3                2                
  Latino              2                2                2                

*^1^Genotype was coded as: SS/SL = 1, LL = 0*.

*\*Significant results are starred*.

Participants were recruited through flyers and online advertisements for a laboratory study of alcohol craving (Ray, [@B33]). Data from this report were culled from the baseline assessment, before any experimental manipulation of alcohol craving took place. Interested individuals called the laboratory to complete telephone screening measures for study eligibility, including the AUDIT. A total of 161 interested individuals were screened over the telephone for eligibility and 72 participants were enrolled in the study. Eligible participants came to the laboratory and completed in-person assessments of depressive symptoms, alcohol use, and alcohol-related problems. All participants provided a saliva sample for DNA analyses. A breath alcohol concentration (BAC) of 0.000 was required upon each laboratory visit. This study was approved by the Human Research Committee at the University of California, Los Angeles. All participants provided written informed consent after receiving a full explanation of the study.

Assessments
-----------

### The Beck depression inventory revised

The Beck is as 23-item measure of depressive symptoms occurring in the past 2 weeks. The Beck Depression Inventory is a widely used measure in psychological research and practice to identify clinical levels of depression symptoms. The Beck depression inventory revised (BDI-II) has high internal consistency (alpha-coefficients for clinical samples ≥ 0.88), and content validity compared with DSM-IV criteria for depression and observer ratings. In addition, the BDI-II is sensitive to symptom changes over time (Richter et al., [@B34]).

### The Rutgers alcohol problem index

The Rutgers alcohol problem index (RAPI) is a 23-item measure used to assess alcohol-related problems in the past year. Possible total scores range from 0 to 69. RAPI items assess the impact of alcohol on social and health functioning (White and Labouvie, [@B42]), and has been found to be valid for use with college-aged participants (Martens et al., [@B27]).

### 30-day timeline follow back interview

The timeline follow back (TLFB) interview was used to assess drinking behavior in the past 30 days. The TLFB is a calendar-assisted interview that was used to obtain data on drinking quantity and frequency. The TLFB accurately estimates alcohol consumption for as long as a 12-month period (Vakili et al., [@B41]). For the purpose of this study, four measures of drinking were derived from the TLFB interview: (a) total number of drinks consumed in the past 30 days;(b) number of drinking days in the past 30 days; (c) number of binge-drinking days in the past 30 days. A binge-drinking episode is defined as consuming four or more drinks for a woman and five or more drinks for a man (Courtney and Polich, [@B9]); and (d) the average number of drinks per drinking day in the past 30 days.

Genotyping
----------

Saliva samples were collected under researcher observation for DNA analyses using Oragene saliva collection kits. Genotyping was performed at the UCLA Genotyping and Sequencing (GenoSeq) Core. Polymerase chain reaction (PCR) primers were labeled with fluorescent dye (6-FAM, VIC, or NED), and PCR was performed on Applied Biosystems dual block PCR thermal cyclers. Microsatellite genotypes were run on an AB 3730 capillary DNA sequencer and analyzed using the AB GeneMapper software version 4.0. The 5-HTTLPR polymorphism at the *SLC6A4* locus was assayed on an AB 7900HT Fast Real-Time PCR System and analyzed using the Sequence Detection Systems (SDS) software version 2.3. Each run included two positive control samples (individual 2 in CEPH family 1347; Coriell Institute). Genotypes were automatically scored by the allele calling software, and each genotype was verified by visual inspection. In process validation checks, the UCLA GenoSeq Core has average call, reproducibility, and concordance rates of 96, 99.7, and 99.8%, respectively. Quality values were computed for each genotype call in this sample, using a standard algorithm that combines various quality metrics. Genotype calls with a quality score of less than 95% were set to fail. The primer sequences resulted in alleles that were 484 bp (S allele) or 528 bp (L allele). Consistent with the existing literature, analyses compared L allele homozygotes to S allele carriers (LL vs. SL/SS).

Data analysis
-------------

Prior to data analysis, study variables were screened for missing data, outliers, and distribution abnormalities. Analyses of variance (ANOVAs) were conducted using the general linear model (Proc GLM) in SAS statistical package. The primary dependent measures in this study were: alcohol-related problems (RAPI score), total number of drinks in the past 30 days, frequency of drinking in the past 30 days, number of days of binge drinking in the past 30 days, and the average number of drinks per drinking day in the past 30 days (all derived from the TLFB interview).

Model parameters consisted of the main effects of depressive symptoms (BDI-II score), *5-HTTLPR* genotype, and depressive symptoms × genotype interaction as predictors of alcohol use and alcohol problems in this sample. In order to maximize statistical power, depressive symptoms were treated as a continuous variable in all analyses. Depressive symptom scores were dichotomized into "high" and "low," using a median split at a score of 8. This dichotomy was used solely for graphically representing the results. In order to quantify effect sizes, partial η^2^s were computed as recommended for ANOVA-based models. Partial η^2^s are defined as the proportion of variance associated with or accounted for by each of the main effects or interactions in the ANOVA model. A dichotomous variable was used for the *5-HTTLPR* genotype (LL = 0, SL and SS = 1). Descriptive statistics and exploratory analyses were conducted using a three-level genotype variable (SS = 0, SL = 1, and LL = 2).

Results
=======

Genotype comparisons
--------------------

Allele frequency did not differ by sex \[χ^2^(2, 68) = 0.68, *p* \> 0.05\], but varied significantly by ethnicity. The SS genotype was more common among African American, Asian, and Latino participants compared with Caucasian participants \[χ^2^(2, 68) = 35.75, *p* \< 0.001; see Table [1](#T1){ref-type="table"}\]. Follow-up analyses were conducted restricting the sample to Caucasian individuals in order to ensure that the findings were not confounded by population stratification. Scores on measures of depressive symptoms, alcohol use, and alcohol problems across genotype are presented in Table [2](#T2){ref-type="table"} and reveal that L allele homozygotes scored significantly higher on alcohol problems, and total reported a higher total number of drinks (*p* \< 0.05) than S allele carriers. Follow-up analyses adding age to the models found no significant main effect of age and there were no significant genotype × age interactions on alcohol use or alcohol problems.

###### 

**Alcohol use, problems, and depressive symptoms by 5-HTTLPR genotype[^1^](#tfn3){ref-type="table-fn"} \[*M* ± (SD)\]**.

  -------------------------------------------------------------------------------------------------------------------------------
                                                SS/SL (*n* = 44)   LL (*n* = 28)   SS/LL vs. LL
  --------------------------------------------- ------------------ --------------- ----------------------------------------------
  RAPI total score\                             17.2 (12.96)       28.22 (17.73)   *t*(70) = −3.04;\
  (possible range:\                                                                *p* = 0.010[\*](#tfn4){ref-type="table-fn"}
  0--69)                                                                           

  BDI-II total score\                           7.25 (7.03)        8.82 (7.69)     *t*(70) = −0.892;\
  (possible range:\                                                                *p* = 0.376
  0--63)                                                                           

  Drinks per drinking day in the past 30 days   5.75 (2.57)        7.12 (3.64)     *t*(70) = 1.386;\
                                                                                   *p* = 0.173

  Drinking days in the past 30 days             9.20 (5.55)        11.67 (5.64)    *t*(70) = 1.90;\
                                                                                   *p* = 0.062[^a^](#tfn5){ref-type="table-fn"}

  Binge-drinking days in the past 30 days       5.76 (4.54)        8.26 (5.70)     *t*(70) = 1.954;\
                                                                                   *p* = 0.055[^a^](#tfn5){ref-type="table-fn"}

  Total drinks in the past 30 days              55.86 (43.88)      90.78 (72.05)   *t*(70) = 2.23;\
                                                                                   *p* = 0.031[\*](#tfn4){ref-type="table-fn"}
  -------------------------------------------------------------------------------------------------------------------------------

*^1^Genotype was coded as: SS/SL = 1, LL = 0*.

*\*Significant results are starred*.

*^a^Trend-level finding*.

*Analyses were repeated with ethnicity as a covariate. Genotype remained a significant predictor of RAPI score (*p* = 0.017). The addition of ethnicity to the model reduced the significance of genotype as a predictor of total drinks to *p* = 0.074*.

Depressive symptoms as moderators of the relationship between 5-HTTLPR genotype and drinking outcomes
-----------------------------------------------------------------------------------------------------

As shown in Table [3](#T3){ref-type="table"}, results revealed a main effect of depressive symptoms on alcohol-related problems in the past year (*p* \< 0.001) and on the total number of drinks consumed in a 30-day period (*p* \< 0.01), such that alcohol-related problems and consumption increased as depressive symptoms increased. No main effects were found for genotype in predicting drinking frequency of drinking or total number of drinks in the past 30 days. There was a significant genotype × depressive symptom interaction on total number of drinks, such that at higher levels of depressive symptoms, participants who were homozygous for the L allele reported significantly higher total number of drinks (mean drinks for individuals above the median BDI-II score = 94.99) compared to S allele carriers (mean drinks for individuals above the median BDI-II score = 48.03; see Figure [1](#F1){ref-type="fig"}). The interaction between BDI-II and *5-HTTLPR* genotype in predicting alcohol problems (RAPI scores) was only marginally significant (*p* = 0.071). Mean RAPI score for L allele homozygotes above the median BDI-II score was 31.57, and 22.94 for S allele carriers. *5-HTTLPR* genotype, BDI-II score, and their interaction were not significant predictors of binge-drinking frequency, the number of drinking days in the past 30 days or the average number of drinks per drinking day; see Table [3](#T3){ref-type="table"}.

###### 

**Main analyses of the effect of depressive symptoms, 5-HTTLPR genotype[^1^](#tfn6){ref-type="table-fn"}, and their interaction on alcohol use and alcohol problems**.

  Dependent variable                                            Model                                                  β        SE       *t*      *p*                                       η^2^
  ------------------------------------------------------------- ------------------------------------------------------ -------- -------- -------- ----------------------------------------- -------
  Total drinks in past 30 days                                  *5-HTTLPR* genotype[^1^](#tfn6){ref-type="table-fn"}   6.988    19.506   0.36     0.721                                     0.002
                                                                BDI-II                                                 3.805    1.344    2.830    0.006[\*](#tfn7){ref-type="table-fn"}     0.105
                                                                Genotype[\*](#tfn7){ref-type="table-fn"}BDI-II         −4.751   1.779    −2.670   0.009[\*](#tfn7){ref-type="table-fn"}     0.095
  Drinking days in past 30 days                                 *5-HTTLPR* genotype                                    −0.124   2.572    −0.050   0.962                                     0.000
                                                                BDI-II                                                 0.261    0.177    1.470    0.146                                     0.031
                                                                Genotype[\*](#tfn7){ref-type="table-fn"}BDI-II         −0.377   0.235    −1.610   0.112                                     0.037
  Drinks per drinking day in past 30 days                       *5-HTTLPR* genotype                                    0.147    1.086    0.135    0.893                                     0.002
                                                                BDI-II                                                 0.088    0.074    1.182    0.241                                     0.054
                                                                Genotype[\*](#tfn7){ref-type="table-fn"}BDI-II         −0.147   0.098    −1.505   0.137                                     0.028
  Binge-drinking days in past 30 days                           *5-HTTLPR* genotype                                    −0.414   1.822    −0.227   0.821                                     0.001
                                                                BDI-II                                                 0.155    0.126    1.231    0.223                                     0.083
                                                                Genotype[\*](#tfn7){ref-type="table-fn"}BDI-II         −0.236   0.166    −1.422   0.160                                     0.051
  Rutgers alcohol problem index score (possible range: 0--69)   *5-HTTLPR* genotype                                    −1.641   5.002    −0.330   0.744                                     0.002
                                                                BDI-II                                                 1.290    0.345    3.740    \<0.001[\*](#tfn7){ref-type="table-fn"}   0.171
                                                                Genotype[\*](#tfn7){ref-type="table-fn"}BDI-II         −0.837   0.456    −1.840   0.071[^a^](#tfn8){ref-type="table-fn"}    0.047

*^1^Genotype was coded as: SS/SL = 1, LL = 0*.

*\*Significant results are starred*.

*^a^Trend-level finding*.

![**Total drinks in the past 30 days (M ± SE) across serotonin transporter genotype (LL vs. SS/SL) and depressive groups (scores on the BDI, split at the median of 8)**. Analyses revealed a significant genotype × BDI interaction such that L allele homozygotes reporting high levels of depressive symptoms reported significantly more drinks in the past 30 days as compared to S allele carriers \[*F*(3, 68) = 7.13, *p* = 0.009, η^2^ = 0.095\].](fpsyt-02-00049-g001){#F1}

Follow-up analyses of genetic effects
-------------------------------------

### Analyses of three levels of genotype

The effects of the *5-HTTLPR* genotype were examined as a three-level variable: SS, SL, and LL. ANOVAs, using Proc GLM, revealed that the interaction of *5-HTTLPR* genotype and depressive symptoms produced a marginally significant increase in total drinks consumed for each additional L allele. In short, analyses of the *5-HTTLPR* as a three-level variable supported the findings achieved with the SS/SL and LL categories and suggest that L allele homozygotes are most distinct from S allele carriers. Consistent with other reports, SS and SL individuals were combined into a single group in order to enhance statistical power.

### Analyses of gender and ethnicity effects

In order to account for the possibility that population stratification confounds the results reported above, we repeated the analyses described above using only self-identified Caucasian individuals (*n* = 51) and by controlling for ethnicity and gender in the full sample. Controlling for ethnicity and gender did not change the results of the main analyses, and revealed a main effect of ethnicity on the total number of drinks consumed in a 30-day period (*p* = 0.002), such that Caucasians had more drinks than any other group (*M* = 83.96, SD = 62.13) followed by Asians (*M* = 37.61, SD = 17.90) and Latinos (*M* = 16.83, SD = 16.50). Only one participant was African American. See Table [4](#T4){ref-type="table"} for full results. Repeating the analyses only in Caucasians significantly decreased statistical power to detect genetic effects. We therefore compared the results of the full sample with the Caucasian sample using partial η^2^s. Effect size estimates are ideal for comparisons with low power, as they are not biased by sample size. Results of analyses among Caucasian individuals revealed that the effect size estimates for the BDI-II × *5-HTTLPR* were reduced slightly. The BDI-II × *5-HTTLPR* genotype interaction on total number of drinks had an estimated partial η^2^ = 0.095 in the full sample (*p* = 0.009), as compared to partial η^2^ = 0.073 (*p* = 0.060) in the Caucasian-only sample. These results suggest that the observed genetic effects are not best explained by ethnicity and provide further support for the findings reported above.

###### 

**Comparison of ANOVA models controlling for ethnicity and gender with main analyses**.

  Dependent variable                                            Model 1                  β         SE       *t*      *p*         η^2^
  ------------------------------------------------------------- ------------------------ --------- -------- -------- ----------- -------
  No of drinks (total) in past 30 days                          *5-HTTLPR* genotype^1^   6.988     19.506   0.360    0.721       0.002
                                                                BDI-II                   3.805     1.344    2.830    0.006\*     0.105
                                                                Genotype\*BDI-II         −4.751    1.779    −2.670   0.009\*     0.095
                                                                Model 2                                                          
                                                                Ethnicity                −18.430   5.827    −3.163   0.002\*     0.058
                                                                *5-HTTLPR* genotype      10.179    18.358   0.554    0.581       0.002
                                                                BDI-II                   3.375     1.270    2.656    0.010\*     0.260
                                                                Genotype\*BDI-II         −4.055    1.686    −2.405   0.019\*     0.085
  Rutgers alcohol problem index score (possible range: 0--69)   Model 1                                                          
                                                                *5-HTTLPR* genotype      −1.641    5.002    −0.330   0.744       0.002
                                                                BDI-II                   1.290     0.345    3.740    \<0.001\*   0.171
                                                                Genotype\*BDI-II         −0.837    0.456    −1.840   0.071^a^    0.047
                                                                Model 2                                                          
                                                                Ethnicity                −0.599    1.600    −0.374   0.709       0.003
                                                                *5-HTTLPR* genotype      −1.538    5.042    −0.305   0.761       0.012
                                                                BDI-II                   1.276     0.349    3.658    0.001\*     0.332
                                                                Genotype\*BDI-II         −0.815    0.436    −1.760   0.083^a^    0.055

*^1^Genotype was coded as: SS/SL = 1, LL = 0*.

*\*Significant results are starred*.

*^a^Trend-level result*.

Discussion
==========

The current study extends the literature on the serotonin transporter polymorphism and its role in AUDs. Results indicated a main effect of 5-HTTLPR genotype such that L allele homozygotes had significantly more alcohol problems measured by the RAPI, and more drinks consumed over a 30-day period than S allele carriers. A main effect of depressive symptoms was found, wherein individuals reporting higher levels of depressive symptoms had more alcohol use and alcohol-related problems than those with fewer depressive symptoms. A significant *5-HTTLPR* × BDI-II interaction was found; higher scores on the BDI-II were associated with more drinks consumed and more drinking days in the past 30 days among L allele homozygotes. Additionally, the interaction of *5-HTTLPR* genotype and BDI-II scores approached significance in predicting more alcohol-related problems in the past year. Follow-up analyses using all three levels of genotype (SS, SL, and LL) revealed that each additional L allele was associated with an increase in drinking problems for participants reporting higher levels of depressive symptoms. These results indicate that the combination of LL genotype and depressive symptomatology is associated with alcohol use and alcohol-related problems. These findings support previous work examining serotonin transporter polymorphism in a mixed clinical sample of depression and AUDs, as well as previous studies examining gene × environment interactions with the *5-HTTLPR* (Olsson et al., [@B30]; Philibert et al., [@B31]; Laucht et al., [@B26]). These results stand in contrast with work on the direct genetic contribution of the serotonin transporter polymorphism to AUDs, as we found no main effect of genotype in the present study (Feinn et al., [@B11]; McHugh et al., [@B28]).

A recent meta-analysis of serotonin transporter polymorphism and AUDs found a main effect of S allele across studies in predicting AUDs, but suggested that comorbid alcohol and depression results in a more complicated picture regarding the effects of the *5-HTTLPR* polymorphism (McHugh et al., [@B28]). The current study offers support for the L allele as a risk for alcohol use problems when depressive symptoms are present. Given that this is a small sample and that few studies have examined the interaction of *5-HTTLPR* and mood symptomatology as a predictor of alcohol problems, these results are preliminary.

Previous work examining interactions between stress and negative life events with the serotonin transporter polymorphism has been mixed, but evidence for the L allele as risk factor has come from both psychosocial (e.g., Olsson et al., [@B30]; Laucht et al., [@B26]) and biological studies (e.g., Philbert) of the serotonin transporter polymorphism. Olsson et al. ([@B30]) reported a G × E interaction between *5-HTTLPR* genotype and risky attachment style in predicting both anxiety symptoms and binge drinking. In risky settings, each additional copy of the *S* allele lowered the odds of anxiety (about 30% per allele), and binge drinking (about 35% per allele; Olsson et al., [@B30]). Laucht et al. ([@B26]) found that high early life adversity and current stressful events interacted with the *5-HTTLPR* genotype to predict the number of binge-drinking days in an adolescent sample. Independent risks for developing an AUD have also been associated with the L allele, including mechanisms of alcohol craving and low level of response to alcohol (Hinckers et al., [@B18]; Bleich et al., [@B4]). The L allele has also been associated with higher rates of AUD and drinking, and a lower age of onset of AUDs (Hu et al., [@B20]; Kweon et al., [@B25]).

The current findings stand in contrast to studies finding a direct relationship between the S allele of the serotonin transporter polymorphism and AUDs. Covault et al. ([@B10]) found that S allele homozygotes with multiple negative life events in the prior year reported more frequent drinking and heavy drinking, stronger intentions to drink, and greater non-prescribed drug use. Among homozygotes for the L allele, drinking and drug use were unaffected by past-year negative life events. More recently, Brody et al. ([@B5]) found that presence of one or two copies of the S allele was associated with increases in substance use over time. However, this association was greatly attenuated by supportive parenting. Johnson ([@B21]) hypothesized that LL genotype is more common among early onset AUDs and that the LL genotype results in reduced levels of intra-synaptic 5-HT. The present results align with and extend previous work implicating the L allele as a risk for alcohol-related problems in young adults with depression symptomatology (Olsson et al., [@B30]; Laucht et al., [@B26]).

While studies examining the relationship between the L allele and alcohol use problems have been conducted in primarily male samples (Laucht et al., [@B26]), the present sample is fairly well balanced on gender across genotype categories. Furthermore, the relationship between the LL genotype and problematic alcohol use in the presence of mood symptoms is corroborated by D:Olsson et al. ([@B30]) large, gender-balanced study of adolescent drinking and the *5-HTTLPR*. This study found that within risky environments, each additional S allele *lowered* the risk of anxiety and drinking problems. Together, these results help elucidate the relative contribution of gender and age factors on the effects of this polymorphism regarding alcohol outcomes.

Strengths of the current study include the careful phenotyping and a sample of young hazardous drinkers. Limitations include the cross-sectional design and the relatively small sample (*n* = 72). While the sample of young heavy drinkers (AUDIT ≥ 8) can be seen as an asset of the study, it also limits the generalizability of the findings to heavy-drinking young adults. Additional study limitations include the temporal coverage of the assessments, as the BDI-II covered a 2-week period while the TLFB comprised a 30-day period. Moreover, the relatively low levels of depressive symptoms in this sample may also limit its generalizability to clinical levels of depression and suggest that further studies in clinical samples are warranted.

On balance, the present findings provide evidence for a genetic contribution of the serotonin transporter polymorphism to alcohol use and alcohol problems among individuals reporting higher levels of depressive symptoms. These results suggest that the LL genotype may confer risk for alcohol problems in the context of co-occurring psychiatric symptoms, which is consistent with, and extends, several recent studies reporting a significant association between the LL genotype and alcohol problems in the presence of environmental stressors (Laucht et al., [@B26]) and comorbid internalizing psychopathology (Olsson et al., [@B30]). Refining the environmental and psychological moderators of the association between genes and clinical outcomes is critical to reconciling mixed findings in psychiatric genetics, including studies of alcoholism vulnerability.
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